Martha J. Carter, Chief Regulatory Officer at Aegerion Pharmaceuticals, Inc. (AEGR), bought 1,000 shares at $14.03 ($14K) on 2012-03-30, disclosed to the SEC on 2012-04-02.
Open-market purchase of $14k AEGR by Chief Regulatory Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ALBO | SELL | 2022-10-25 | $2K | — | Filing → |
| ALBO | SELL | 2022-07-25 | $3K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $3K | — | Filing → |